J Hagan Capital Inc. Buys Shares of 600 Intuitive Surgical, Inc. (NASDAQ:ISRG)

J Hagan Capital Inc. bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 600 shares of the medical equipment provider's stock, valued at approximately $313,000.

Several other institutional investors and hedge funds also recently made changes to their positions in ISRG. Atala Financial Inc acquired a new stake in Intuitive Surgical during the 4th quarter worth about $25,000. Chilton Capital Management LLC increased its position in Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after buying an additional 43 shares during the period. Parvin Asset Management LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $26,000. Global Financial Private Client LLC boosted its stake in Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after buying an additional 38 shares in the last quarter. Finally, Elite Financial Inc. acquired a new stake in Intuitive Surgical in the 1st quarter valued at $26,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, EVP Gary Loeb sold 1,700 shares of the stock in a transaction dated Friday, April 25th. The stock was sold at an average price of $513.18, for a total transaction of $872,406.00. Following the transaction, the executive vice president directly owned 2,245 shares in the company, valued at approximately $1,152,089.10. This represents a 43.09% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Mark Brosius sold 216 shares of the stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the transaction, the senior vice president directly owned 907 shares of the company's stock, valued at $510,740.77. This represents a 19.23% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 4,998 shares of company stock valued at $2,611,577. 0.70% of the stock is owned by company insiders.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Barclays cut their price target on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. Robert W. Baird dropped their price target on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Royal Bank Of Canada dropped their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Evercore ISI raised their price target on Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research note on Tuesday. Finally, Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a "hold" rating to a "sell" rating and reduced their target price for the stock from $515.00 to $440.00 in a research note on Monday, June 9th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average target price of $592.59.

Intuitive Surgical Stock Performance

NASDAQ ISRG traded down $7.41 during trading hours on Tuesday, reaching $527.30. 1,608,552 shares of the company's stock were exchanged, compared to its average volume of 1,672,097. Intuitive Surgical, Inc. has a one year low of $413.82 and a one year high of $616.00. The company's 50-day moving average is $537.53 and its two-hundred day moving average is $536.99. The company has a market capitalization of $188.99 billion, a price-to-earnings ratio of 77.32, a price-to-earnings-growth ratio of 5.67 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same period in the prior year, the firm posted $1.50 EPS. Research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.